| Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1 Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP ... Arch ophthalmol 117, 1329-1345, 1999 | 2036 | 1999 |
| Age-related macular degeneration RD Jager, WF Mieler, JW Miller New England Journal of Medicine 358 (24), 2606-2617, 2008 | 1997 | 2008 |
| Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy AP Adamis, JW Miller, MT Bernal, DJ D'Amico, J Folkman, TK Yeo, ... American journal of ophthalmology 118 (4), 445-450, 1994 | 1704 | 1994 |
| Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult … VIPTS Group1A American journal of ophthalmology 131 (5), 541-560, 2001 | 1043* | 2001 |
| Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model JW Miller, AP Adamis, DT Shima, PA D'Amore, RS Moulton, MS O'Reilly, ... The American journal of pathology 145 (3), 574, 1994 | 976 | 1994 |
| Inhibition of vascular endothelial growth factor prevents retinal ischemia—associated iris neovascularization in a nonhuman primate AP Adamis, DT Shima, MJ Tolentino, ES Gragoudas, N Ferrara, ... Archives of ophthalmology 114 (1), 66-71, 1996 | 841 | 1996 |
| Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ... Archives of ophthalmology 120 (3), 338-346, 2002 | 817 | 2002 |
| Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate MJ Tolentino, JW Miller, ES Gragoudas, FA Jakobiec, E Flynn, ... Ophthalmology 103 (11), 1820-1828, 1996 | 704 | 1996 |
| Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ... Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010 | 615 | 2010 |
| VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization S Ishida, T Usui, K Yamashiro, Y Kaji, S Amano, Y Ogura, T Hida, ... The Journal of experimental medicine 198 (3), 483-489, 2003 | 593 | 2003 |
| Diffusion of high molecular weight compounds through sclera J Ambati, CS Canakis, JW Miller, ES Gragoudas, A Edwards, ... Investigative ophthalmology & visual science 41 (5), 1181-1185, 2000 | 533 | 2000 |
| Tumor necrosis factor-α mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma T Nakazawa, C Nakazawa, A Matsubara, K Noda, T Hisatomi, H She, ... Journal of Neuroscience 26 (49), 12633-12641, 2006 | 515 | 2006 |
| Vascular endothelial growth factor a in intraocular vascular disease JW Miller, J Le Couter, EC Strauss, N Ferrara Ophthalmology 120 (1), 106-114, 2013 | 471 | 2013 |
| Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study JW Miller, U Schmidt-Erfurth, M Sickenberg, CJ Pournaras, H Laqua, ... Archives of ophthalmology 117 (9), 1161-1173, 1999 | 465 | 1999 |
| Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate MJ Tolentino, JW Miller, ES Gragoudas, K Chatzistefanou, N Ferrara, ... Archives of Ophthalmology 114 (8), 964-970, 1996 | 453 | 1996 |
| Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study U Schmidt-Erfurth, JW Miller, M Sickenberg, H Laqua, I Barbazetto, ... Archives of Ophthalmology 117 (9), 1177-1187, 1999 | 425 | 1999 |
| Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ... Ophthalmology 110 (4), 667-673, 2003 | 406 | 2003 |
| Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy JW Miller, AP Adamis, LP Aiello Diabetes/metabolism reviews 13 (1), 37-50, 1997 | 390 | 1997 |
| Anti-vascular endothelial growth factor therapy for ocular neovascular disease CM Andreoli, JW Miller Current opinion in ophthalmology 18 (6), 502-508, 2007 | 387 | 2007 |
| Maximum tolerated dose of a humanized anti–vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration PJ Rosenfeld, SD Schwartz, MS Blumenkranz, JW Miller, JA Haller, ... Ophthalmology 112 (6), 1048-1053. e4, 2005 | 348 | 2005 |
